At the molecular level, H3.3G34R, ATRX, and TP53 mutations cooperate to affect RNA splicing through suppression of intron retention, leading to increased expression of NOTCH2NL and eventually promoting tumor growth and survival (81). Here, ATRX is linked to neoplasm.